FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis

FRA:FRE • DE0005785604

51.72 EUR
-0.34 (-0.65%)
Last: Feb 23, 2026, 05:36 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to FRE. FRE was compared to 32 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FRE get a neutral evaluation. Nothing too spectacular is happening here. FRE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year FRE was profitable.
  • In the past year FRE had a positive cash flow from operations.
  • Of the past 5 years FRE 4 years were profitable.
  • Each year in the past 5 years FRE had a positive operating cash flow.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

  • FRE has a Return On Assets (2.69%) which is comparable to the rest of the industry.
  • FRE has a Return On Equity (6.14%) which is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 3.26%, FRE is not doing good in the industry: 71.88% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for FRE is significantly below the industry average of 6.99%.
  • The last Return On Invested Capital (3.26%) for FRE is above the 3 year average (1.83%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 3.26%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

  • With an excellent Profit Margin value of 5.11%, FRE belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
  • FRE's Profit Margin has declined in the last couple of years.
  • FRE has a Operating Margin of 9.76%. This is amongst the best in the industry. FRE outperforms 87.50% of its industry peers.
  • FRE's Operating Margin has declined in the last couple of years.
  • FRE has a Gross Margin (24.99%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of FRE has declined.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

  • FRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • FRE has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for FRE has been increased compared to 5 years ago.
  • FRE has a better debt/assets ratio than last year.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.12 indicates that FRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • FRE has a Altman-Z score of 2.12. This is comparable to the rest of the industry: FRE outperforms 59.38% of its industry peers.
  • FRE has a debt to FCF ratio of 11.17. This is a negative value and a sign of low solvency as FRE would need 11.17 years to pay back of all of its debts.
  • FRE has a Debt to FCF ratio (11.17) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
  • FRE's Debt to Equity ratio of 0.61 is amongst the best of the industry. FRE outperforms 84.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Altman-Z 2.12
ROIC/WACC0.6
WACC5.44%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • FRE has a Current Ratio of 1.26. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
  • FRE has a better Current ratio (1.26) than 65.63% of its industry peers.
  • FRE has a Quick Ratio of 1.26. This is a bad value and indicates that FRE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of FRE (0.99) is better than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 215.74% over the past year.
  • Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
  • Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 2.13% in the last year.
  • FRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.22% yearly.
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%

3.2 Future

  • FRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.27% yearly.
  • The Revenue is expected to grow by 4.51% on average over the next years.
EPS Next Y13.8%
EPS Next 2Y12.74%
EPS Next 3Y11.84%
EPS Next 5Y10.27%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.51%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 15.17, FRE is valued correctly.
  • Based on the Price/Earnings ratio, FRE is valued a bit cheaper than 71.88% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, FRE is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 13.52, FRE is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FRE indicates a somewhat cheap valuation: FRE is cheaper than 71.88% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of FRE to the average of the S&P500 Index (28.02), we can say FRE is valued rather cheaply.
Industry RankSector Rank
PE 15.17
Fwd PE 13.52
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • FRE's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, FRE is valued a bit more expensive than 71.88% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.3
EV/EBITDA 11.05
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • FRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.1
PEG (5Y)N/A
EPS Next 2Y12.74%
EPS Next 3Y11.84%

3

5. Dividend

5.1 Amount

  • FRE has a Yearly Dividend Yield of 1.98%. Purely for dividend investing, there may be better candidates out there.
  • FRE's Dividend Yield is a higher than the industry average which is at 1.65.
  • Compared to an average S&P500 Dividend Yield of 1.81, FRE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2016 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

  • 59.84% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y12.74%
EPS Next 3Y11.84%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

FRA:FRE (2/23/2026, 5:36:15 PM)

51.72

-0.34 (-0.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners46.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.13B
Revenue(TTM)22.35B
Net Income(TTM)1.14B
Analysts85.22
Price Target56.38 (9.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)0.75%
PT rev (3m)2.85%
EPS NQ rev (1m)2.29%
EPS NQ rev (3m)1.11%
EPS NY rev (1m)0%
EPS NY rev (3m)0.33%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.14%
Valuation
Industry RankSector Rank
PE 15.17
Fwd PE 13.52
P/S 1.3
P/FCF 24.3
P/OCF 13.38
P/B 1.56
P/tB 15.73
EV/EBITDA 11.05
EPS(TTM)3.41
EY6.59%
EPS(NY)3.83
Fwd EY7.4%
FCF(TTM)2.13
FCFY4.12%
OCF(TTM)3.87
OCFY7.47%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)1.1
PEG (5Y)N/A
Graham Number50.37
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 3.26%
ROICexc 3.7%
ROICexgc 8.63%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2.12
F-Score7
WACC5.44%
ROIC/WACC0.6
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
EPS Next Y13.8%
EPS Next 2Y12.74%
EPS Next 3Y11.84%
EPS Next 5Y10.27%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.51%
EBIT growth 1Y51.21%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.95%
EBIT Next 3Y24.42%
EBIT Next 5Y15.77%
FCF growth 1Y-61.64%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-52.6%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What is the fundamental rating for FRE stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status for FRE stock?

ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


What is the expected EPS growth for FRESENIUS SE & CO KGAA (FRE.DE) stock?

The Earnings per Share (EPS) of FRESENIUS SE & CO KGAA (FRE.DE) is expected to grow by 13.8% in the next year.


How sustainable is the dividend of FRESENIUS SE & CO KGAA (FRE.DE) stock?

The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 59.84%.